December 2004

  

"ISPOR e-BULLETIN" provides updates of recent ISPOR activities and events. For detailed information on ISPOR activities, members are encouraged to go to www.ispor.org.

 

Please pass these updates along to your colleagues.

  eBulletin Index

 

NEW THIS MONTH

 

**NEW** Value In Health, Vol. 7, Issue 6 November/December 2004

**NEW** 10th International Meeting Call For Abstract Now Online

**NEW** 10th International Meeting ISPOR Short Courses

**NEW** Medication Compliance Sig – Consensus Definitions For Medication Compliance/Adherence And Medication Persistence

**NEW** Medication Compliance Sig – New Chair For Economics Of Compliance Working Group

**NEW** Patient Registry SIG Survey

**NEW** New Retrospective Database SIG Working Groups Selected

**NEW** Risk Management SIG Medication Risk-Benefit Survey

**COMING SOON** QOL SIG Cross-Cultural & Translational Adaptation Working Group Paper

**NEW** ISPOR Avedis Donabedian Outcomes Research Lifetime Achievement Award

**NEW** Statistical Scientist – Outcomes Research (Associate Director) Position Available At Pfizer

 

ISPOR ONGOING ACTIVITIES

 

1.       Publications

2.       Meetings and Congresses

3.       Educational Activities

4.       Student News

5.       ISPOR Special Interest Groups

6.       Committee and Task Force Activities

7.       Hot Topics

8.       Important Dates to Remember

9.       Employment in Pharmacoeconomics and Outcomes Research

10.    Membership

 


  1. PUBLICATIONS

Top

 

VALUE IN HEALTH

 

Value in Health: Volume 7, Issue 6, November/December 2004, which includes the 7th Annual European Congress abstracts, is online and available this month at: http://www.ispor.org/valueinhealth_index.asp.

 

CONTRIBUTED PODIUM PRESENTATIONS

Value in Health; Volume 7, Issue 6, Page 637

CONTRIBUTED POSTER PRESENTATIONS: Session I

Value in Health; Volume 7, Issue 6, Page 658

CONTRIBUTED POSTER PRESENTATIONS: Session II

Value in Health; Volume 7, Issue 6, Page 731

DISCLOSURE INFORMATION

Value in Health; Volume 7, Issue 6, Page 806

AUTHOR INDEX

Volume in Health; Volume 7, Issue 6, Page 811

SUJECT INDEX

Volume in Health; Volume 7, Page 820

 

 

HEALTH CARE COST, QUALITY, AND OUTCOMES: ISPOR BOOK OF TERMS  

 

This ISPOR publication includes more than 100 detailed monographs covering over 400 terms used in health care delivery, management, and regulation, as well as health care outcomes research including clinical, economic, and quality-of-life research terms. ISPOR member discounted price is $36.00; a 40% discount!  Student/Library/Academic discounted price: $33.00 (a 45% discount). On-line ordering is now available at: http://www.ispor.org/publications/lexicon_index.asp.  Contact Stephen Priori at spriori@ispor.org for information on orders over 1000. 

 


  

  1. ISPOR MEETINGS AND CONGRESSES

Top

   

10TH ANNUAL INTERNATIONAL MEETING

May 15-18, 2005, Marriott Wardman Park Hotel, Washington, DC, USA

 

**NEW**CALL FOR ABSTRACTS AVAILABLE ONLINE

SUBMIT YOUR ABSTRACT NOW!

Abstract Deadline: 10 January 2005

Early Registration Deadline: 19 April 2005

 

MEETING AT A GLANCE

http://www.ispor.org/meetings/washington0505/index.asp

 

EXHIBIT SPACE, contract available online at

 

SPONSORSHIP Opportunities are available, for more information go to


 

  1. EDUCATION ACTIVITIES

Top

           

**NEW** ISPOR SHORT COURSES

Saturday, May 14th & Sunday May 15th, 2005 - Prior to the ISPOR 10th Annual International Meeting

 

**For short course descriptions and faculty information go to:

 

Saturday, May 14th: http://www.ispor.org/meetings/washington0505/sc14.asp

Sunday, May 15th: http://www.ispor.org/meetings/washington0505/sc15.asp

 

 

Pharmacoeconomics Courses:


Pharmacoeconomics for Decision-makers – Saturday Full Day Course (8:00am-5:00pm)


Elements of Pharmaceutical Pricing – Sunday Morning Course (8:00am-12:00pm)

 

Clinical Assessment Courses:


Retrospective Database Analysis: Data sources and Methods – Saturday Full Day Course (8:00am-5:00pm)


Meta-Analysis and Systematic Literature Review – Sunday Morning Course (8:00am-12:00pm)

 

Modeling Courses:


Bayesian Analysis: Overview – Saturday Morning Course (8:00am-12:00pm)

 

Bayesian Analysis: Applications – Saturday Afternoon Course (1:00pm-5:00pm)


Modeling: Structure & Design of Model – Sunday
Full Day Course (8:00am-5:00pm)

 

Discrete Event Simulation for Economic Analyses - Sunday Afternoon Course (1:00pm-5:00pm)

 

Introduction to Decision Analysis – Sunday Afternoon Course (1:00pm-5:00pm)

 

Quality of Life/Patient-reported Outcomes Courses:


Introduction to Quality of Life/Patient-Reported Outcomes – Saturday Afternoon Course (1:00pm-5:00pm)


Old and New Utility Measures in Health Economics and Outcomes Research – Sunday Morning Course (8:00am-12:00pm)

 

Advanced Quantitative Methods for Quality of Life/Patient-reported Outcomes Research – Sunday Afternoon Course (1:00pm-5:00pm)

 

Economic Analysis Courses:


Financial Impact / Cost of Illness – Saturday Afternoon Course (1:00pm-5:00pm)


Cost Estimation: Finding and Extracting Cost Data – Sunday Morning Course (8:00am-12:00pm)


Statistical Considerations in Economic Evaluations – Sunday Afternoon Course (1:00pm-5:00pm)

 


**COMING THIS MONTH** NEW ISPOR Distance Learning Program Modules

             ISPOR Distance Learning Program

 

Modules on the Pharmacoeconomics in Drug Development, Reimbursement and Marketing

·  Pharmacoeconomics in Drug Development and Marketing: An Overview     

·  Drug Development - Pre-Phase II Pharmacoeconomic Activities

·  Drug Development- Phase II Pharmacoeconomic Activities

·  Drug Development – Phase III Pharmacoeconomic Activities

·  Drug Development – Phase IIIB and Pre-Market Entry Pharmacoeconomic Activities

 

The following module topics are currently available:

 

Pharmacoeconomics

Pharmacoeconomic Evaluations &  Methods

Cost-Effectiveness Analysis

Cost-Benefit Analysis

Cost-Utility Analysis

Humanistic Outcomes (Utilities, Health-related Quality of Life, Patient-reported Outcomes, Patient Preferences)

Study Design in Pharmacoeconomics

Guidelines and Reference Standards

 


 

  1. STUDENT NEWS

Top

Visit ISPOR Internship- Professional Recruitment Assistance Program (I-PRAP)

STUDENTS have the opportunity to search for internship positions available and post their CVs/resumes for employers to view. Post your CV today!

EMPLOYERS have the opportunity to access CVs/resumes from interested students.
 

For more details on the ISPOR Student Network, please visit: http://www.ispor.org/student/student_index.asp

          


 

 

  1. ISPOR SPECIAL INTEREST GROUPS (SIG)

Top

 

MEDICATION COMPLIANCE SIG

**NEW** Medication Compliance SIG – Consensus Definitions for Medication Compliance/Adherence and Medication Persistence

Consensus definition of key terms will have a considerable impact on effective outcomes research.  The Issues and Definitions Workgroup, chaired by Peter Wong have proposed draft consensus definitions for Medication Compliance/Adherence and Medication Persistence. View the definitions and give your comments – http://www.ispor.org/surveys/MedComp/default.asp. Deadline December 20th 2004

 

 

**NEW**Medication Compliance SIG – New Chair for Economics of Compliance Working Group

Dyfrig Hughes, PhD (Senior Research Fellow in Pharmacoeconomics and Director, Centre for the Economics of Health, University of Wales, Bangor) is welcomed as the new chair of the ECON Working Group.  Leadership and Reference group members are needed.  E-mail interest to medcompsig@ispor.org   

 

            For more details on this SIG, please visit: http://www.ispor.org/sigs/medication.asp

 

PATIENT REGISTRY SIG

           

            **NEW** Patient Registry SIG Survey

The Patient Registry SIG Survey results are currently being compiled.  Over 300 ISPOR members participated in the survey.

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/patient_registr.asp

 

RETROSPECTIVE DATABASE SIG

           

         **NEW** New Working Group Selected

            This SIG is under new leadership.  The new Working Groups are:

 

·          Classification of Databases

·          Policy Advocacy

·          Research Design & Analysis

·          Database Development

·          Privacy Regulations

 

If you would like to participate, e-mail your interest, working group, and leadership interest to rdsig@ispor.org.

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/retrospective_db.asp

 

QUALITY OF LIFE SIG

**COMING SOON** Cultural & Translational Adaptation Task Force Paper

The QOL SIG Cultural & Translational Adaptation Task Force Paper, “Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient Reported Outcomes (PRO) Measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation,” will appear in Value in Health, Volume 8, Issue 2, available in April 2005.

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/qol.asp

 

HEALTH TECHNOLOGY ASSESSMENT SIG

 

For more details on this SIG, please visit http://www.ispor.org/sigs/hta.asp

 

RISK MANAGEMENT SIG

 

            **NEW** Medication Risk-Benefit Survey

            A medication risk-benefit survey is currently being developed.

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/rm.asp

   
MANAGED
CARE SIG

 

For more details, please visit http://www.ispor.org/sigs/sigsindex.asp

 

CLINICAL PRACTICE SIG

 

For more details, please visit: http://www.ispor.org/sigs/sigsindex.asp

 

Special Interest Group membership is open to ALL ISPOR members. To JOIN any SIG: http://www.ispor.org/sigs/joinsig.htm

 


 

 

  1. ISPOR BOARD, COMMITTEE, AND TASK FORCE ACTIVITIES

Top

 

            ISPOR 2005-2006 BOARD OF DIRECTORS CALL FOR NOMINATIONS

ISPOR is a member-driven organization.  As a member-driven organization, its governance is determined by the membership.  The ISPOR Nominations Committee is seeking qualified candidates for the position of PRESIDENT-ELECT and 2 DIRECTOR positions.

 

You, as an ISPOR member, are invited to submit your name if you wish to be considered for a position on the ISPOR BOARD OF DIRECTORS.  You may also recommend the name of another ISPOR member.  Please email your interest or recommendation to: nominations@ispor.org.

 

Please attach a curriculum vitae.  The deadline for submitting nominations is Monday, February 2, 2005.

 

      AWARD COMMITTEE ACTIVITIES

 

 

**NEW** ISPOR AVEDIS DONABEDIAN OUTCOMES RESEARCH LIFETIME ACHIEVEMENT  AWARD

 

The ISPOR Awards Committee is seeking nominees for the ISPOR Avedis Donabedian Outcomes Research Lifetime Achievement Award.

 

See http://www.ispor.org/awards/donabedian_.asp

For award description, criteria, selection process, nature of the award, and past recipients.

 

The deadline to submit nominees is DECEMBER 15, 2004.

 

ISPOR RESEARCH EXCELLENCE AWARDS CALL FOR NOMINATIONS

 

The ISPOR Awards Committee is seeking nominees for both the ISPOR Research Excellence Award for Methodology Excellence and Research Excellence Award for Practical Application Excellence.

 

See http://www.ispor.org/awards/methodology_.asp and http://www.ispor.org/awards/application_.asp for Excellence Awards descriptions, criteria, selection process, nature of award, and past recipients.

 

ISPOR BERNIE O’BRIEN NEW INVESTIGATOR AWARDS CALL FOR  NOMINATIONS

 

The ISPOR Bernie O’Brien New Investigator Award was established in 2004 to honor the long-standing commitment of Bernie J. O’Brien, PhD to training and mentoring new scientists in the fields of outcomes research and pharmacoeconomics.  The award will be presented for the first time at the ISPOR 10th Annual International Meeting in Washington, DC, 15-18, 2005.

 

The ISPOR Awards Committee is seeking nominees for this award. See http://www.ispor.org/awards/Obrien_investigator.asp for descriptions, criteria, selection process, and nature of the award.

 

      The deadline to submit nominees for both awards is FEBRUARY 15, 2005.

 

 

HEALTH SCIENCE INITIATIVE: RCT-CEA TASK FORCE

 

            The RCT-CEA final draft document is now available for all ISPOR Members to review on our website at:

            http://www.ispor.org/workpaper/RCT_CEA/RCT-CEAreport_refgroup111204.pdf.

 

You are invited to comment on the ISPOR Task Force document titled: Best Practices For Economic Analysis Alongside Clinical Trials:  An ISPOR RCT-CEA Task Force Report.  For information on submitting your comments please refer to our website link at http://www.ispor.org/surveys/research_practices/default.asp and follow the instructions.

 

            The deadline for comments is December 20, 2004.

 


  1. HOT TOPICS

Top

 

CMS SEEKS PUBLIC COMMENT ON STANDARDIZED QUALITY MEASURES

MEASURES RECOMMENDED FOR AMBULATORY CARE AND PATIENT PERSPECTIVES ON HOSPITAL CARE

 

WASINGTON D.C. – (November 16, 2004) – Medicare is taking another important step to improve the quality of healthcare by identifying and requesting public comment on standard information to be used to publicly report both on how well a physician treats certain illnesses and patient perspectives on the quality of care received during a hospital stay.

 

For full text of the article, go to: http://www.cms.hhs.gov/media/press/release.asp?Counter=1259

 


 

  1. IMPORTANT DATES TO REMEMBER

Top

 

December 31, 2004 – Submission deadline for nominees for ISPOR 2005 Avedis Donabedian Outcomes Research Lifetime Achievement Award.

 

January 10, 2005 - Abstract Submission deadline for the ISPOR 10th Annual International Meeting.

 

February 2, 2005 Submission deadline for nominees for ISPOR 2005-2006 Board of Directors positions.

 

February 15, 2005 – Submission deadline for nominees for ISPOR Research Excellence Awards and Bernie J. O’Brien  New Investigator Award.

 

April 19, 2005 – Early Meeting registration and hotel reservation deadline for the ISPOR 10th Annual International Meeting, Marriott Wardman Park Hotel, Washington, DC.

 

May 15-18 2005 ISPOR 10th Annual International Meeting, Marriott Wardman Park Hotel, Washington, DC.

 

June 20, 2005 Abstract Submission deadline for the ISPOR 8th Annual European Congress.


  1. EMPLOYMENT

Top

**NEW** 14 NEW POSITIONS AT THE ISPOR WEBSITE: Careers

 

            Advertise your positions on ISPOR Website (1 million hits per month)

 

            FREE LISTING OF INTERNSHIPS

Visit ISPOR’s Internship-Professional Recruitment Assistance Program (I-PRAP) at

 

Over 60 student resumes posted! I-PRAP is an ONLINE, FREE service available to ISPOR members. 

 

STUDENTS have the opportunity to search for internship positions available and post their CVs/resumes for employers to view. 

EMPLOYERS have the opportunity to post their Intern positions available and access CVs/resumes from interested students.

 

Any questions, please contact: iprap@ispor.org.

 

 

**NEW**Statistical Scientist – Outcomes Research (Associate Director) With Pfizer

Position Available

 

Statistical Scientist – Outcomes Research (Associate Director)

 

Imagine a career that touches the lives of people everywhere.  Imagine an opportunity to reach beyond your area of expertise to make an impact on something greater than the bottom line.  Imagine playing a key role in some of the most critical issues facing healthcare today.  This is your career at Pfizer – a career unlike any other.

 

Partner with our Outcomes Research (OR) scientists to develop effective OR product support programs that make optimal use of available data sources and statistical methods.

Your contributions will provide technical statistical support to outcomes research projects and ensure sound statistical input to the development of health outcomes measurements, preparation of statistical analysis plans, interpretation of statistical results, and production of reporting displays for outcomes research projects.   You will also ensure that sound statistical principles are applied in Exploratory Data Analysis, data mining and meta-analysis of health outcomes databases.  This is an excellent opportunity to collaborate with Outcomes Research scientists and Biostatistics Therapeutic Area Heads to identify opportunities for exploratory analyses and data mining of health outcomes databases.  You will be expected to both communicate and collaborate with clinical project statisticians within the therapeutic areas to ensure consistency of statistical approaches and alignment of statistical analyses of health outcomes with overall product marketing strategy.

 

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status.  Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment.

 

For more details and to open the dialogue for consideration please go to www.pfizer.com/careers and apply to requisition 039670.

 

               


  1. ISPOR MEMBERSHIP

Top

Update your email address at https://www.ispor.org/members/MemberProfile.aspx! Your email address is required as part of your log in information in the members only section of the ISPOR website. 

 

 


eBulletin Index